US Edition
News from Cardiovascular News
We’ve assigned a rating of Unknown factuality to Cardiovascular News. You can read more about how we’ve determined Cardiovascular News’s credibility and reliability as a news source here: https://ground.news/rating-system.
Information about Cardiovascular News
Where is Cardiovascular News located?Cardiovascular News's WebsiteMedia Bias Ratings
Do you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top Cardiovascular News News
Taiwan · TaiwanTaho Pharmaceuticals has announced the submission of its new drug application (NDA) to the US Food and Drug Administration (FDA) for TAH3311, apixaban oral dissolving film (ODF). TAH3311 is an innovative formulation designed to improve the delivery of apixaban, a widely used anticoagulant. Developed on Taho’s proprietary transepithelial delivery system (TDS) platform, TAH3311 is formulated as an easy-to-use oral dissolving film (ODF). According …See the Story
Taho Pharma Submits New Drug Application to US FDA for Apixaban Oral Dissolving Film - Cardiovascular News
100% Center coverage: 1 sources
